Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/29052
Type
ArticleCopyright
Restricted access
Embargo date
2030-01-01
Collections
- IOC - Artigos de Periódicos [12967]
Metadata
Show full item record
DIVERGENCE OF MACROPHAGE PHAGOCYTIC AND ANTIMICROBIAL PROGRAMS IN LEPROSY
Imunidade Inata
Infecções Bacterianas
macrófagos fagocitários
programas antimicorbianos
Author
Affilliation
University of California Los Angeles. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Division of Cardiology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Los Angeles/Orthopaedic Hospital Department of Orthopedic Surgery,. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA.
University of Miami School of Medicine. Department of Dermatology and Cutaneous Surgery. Miami, FL, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de |Micobactérias. Rio de Janeiro, RJ. Brasil.
University of Southern California School of Medicine. Department of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Los Angeles/Orthopaedic Hospital Department of Orthopedic Surgery,. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Los Angeles/Orthopaedic Hospital Department of Orthopedic Surgery,. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA / University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Division of Cardiology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Los Angeles/Orthopaedic Hospital Department of Orthopedic Surgery,. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA.
University of Miami School of Medicine. Department of Dermatology and Cutaneous Surgery. Miami, FL, USA.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de |Micobactérias. Rio de Janeiro, RJ. Brasil.
University of Southern California School of Medicine. Department of Dermatology. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Los Angeles/Orthopaedic Hospital Department of Orthopedic Surgery,. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Los Angeles/Orthopaedic Hospital Department of Orthopedic Surgery,. Los Angeles, CA, USA.
University of California Los Angeles. David Geffen School of Medicine. Department of Microbiology and Molecular Genetics. Los Angeles, CA, USA / University of California Los Angeles. David Geffen School of Medicine. Department of Medicine. Division of Dermatology. Los Angeles, CA, USA.
Abstract
Effective innate immunity against many microbial pathogens requires macrophage programs that upregulate phagocytosis and direct antimicrobial pathways, two functions generally assumed to be coordinately regulated. We investigated the regulation of these key functions in human blood-derived macrophages. Interleukin-10 (IL-10) induced the phagocytic pathway, including the C-type lectin CD209 and scavenger receptors, resulting in phagocytosis of mycobacteria and oxidized low-density lipoprotein. IL-15 induced the vitamin D-dependent antimicrobial pathway and CD209, yet the cells were less phagocytic. The differential regulation of macrophage functional programs was confirmed by analysis of leprosy lesions: the macrophage phagocytosis pathway was prominent in the clinically progressive, multibacillary form of the disease, whereas the vitamin D-dependent antimicrobial pathway predominated in the self-limited form and in patients undergoing reversal reactions from the multibacillary to the self-limited form. These data indicate that macrophage programs for phagocytosis and antimicrobial responses are distinct and differentially regulated in innate immunity to bacterial infections.
Keywords in Portuguese
HanseníaseImunidade Inata
Infecções Bacterianas
macrófagos fagocitários
programas antimicorbianos
Share